151 results

• FDA Approves Wegovy for Treatment of Obesity-Related Heart Problems, Despite Gastroparesis Risks

  March 11, 2024

  Irvin Jackson

  The FDA has approved Wegovy for use in preventing heart disease, heart attacks and strokes caused by obesity.

• Eli Lilly Warns About Potential Health Risks From Mounjaro, Zepbound Counterfeit Versions

  March 8, 2024

  Irvin Jackson

  Eli Lilly warns that compounded and fake versions of Mounjaro and Zepbound carry potential health risks, and warn that even the legal versions of the drugs should not be used for cosmetic weight loss.

• Gastroparesis Lawsuit Filed Over Side Effects of Ozempic and Trulicity

  March 7, 2024

  Irvin Jackson

  A gastroparesis lawsuit filed by a Pennsylvania woman claims a failure to provide adequate drug warnings led to her suffering stomach paralysis and bowel obstructions.

• Lawsuit Over Mounjaro Intestinal Obstructions, Gastroparesis Diagnosis Filed Against Eli Lilly

  February 26, 2024

  Irvin Jackson

  A Mounjaro intestinal obstruction and gastroparesis lawsuit claims side effects of the diabetes drug left a woman with severe and permanent injuries, including sepsis and the need for a colostomy bag.

• MDL Judge Schedules Initial Conference for Lawsuits Over Ozempic, Wegovy and Other GLP-1 RA Drugs

  February 23, 2024

  Irvin Jackson

  A federal judge has scheduled the initial status conference for coordinated GLP-1 RA drug stomach paralysis lawsuit pretrial proceedings for March 14.

• Psychiatric Side Effects Linked to Ozempic, Wegovy and Other Popular GLP-1 Drugs in New Study

  February 20, 2024

  Irvin Jackson

  A new study reveals that Ozempic, Mounjaro and similar drugs are linked to an increased risk of psychiatric adverse events, including eating disorders, stress and insomnia.

• Ozempic Intestinal Blockage Lawsuit Filed Over Failed To Disclose Extent of Serious Stomach Risks

  February 12, 2024

  Irvin Jackson

  An Ozempic intestinal blockage lawsuit claims the drug's manufacturers failed to warn patients and the medical community of potentially severe and permanent injuries linked to the diabetes drug.

• Nausea and Vomiting from Ozempic, Wegovy, Similar GLP-1 Drugs Increases with High Doses: Study

  February 7, 2024

  Russell Maas

  A new study finds increased risk of nausea, vomiting and gastric illnesses associated with Ozempic, Wegovy, Mounjaro and other types of GLP-1 drugs commonly prescribed for Type II diabetes and weight loss management.

• GLP1 Lawsuits Consolidated In One MDL, Combining Stomach Paralysis Claims Involving Ozempic, Wegovy and Mounjaro

  February 5, 2024

  Irvin Jackson

  A panel of federal judges has consolidated all GLP-1 stomach paralysis lawsuits before one federal judge for coordinated pretrial proceedings, including claims against the makers of Ozempic, Wegovy and Mounjaro.

• Fake Ozempic Linked to Hypoglycemia Injuries, Poison Centers Warn

  January 25, 2024

  Irvin Jackson

  American Poison Centers have seen several cases of hypoglycemia linked to fake Ozempic products, according to a Reuters report.